Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Abediterol Nebulizers vs DPI in Healthy Subjects
NCT04199598Phase 1Terminated
- Sponsor
- AstraZeneca
- Start
- Jan 2020
- Primary completion
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of abediterol in chronic obstructive pulmonary disease (COPD) (4 arms), sponsored by AstraZeneca. Primary endpoints: Area under plasma concentration-time curve, Area under plasma concentration-time curve from zero to last quantifiable concentration and 1 more. Started Jan 2020; status: terminated.
02
Drugs
abediterol
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT04199598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04199598.